HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity.

Abstract
We have examined the intranasal administration of a vaccine against Mycobacterium tuberculosis (M.tb) consisting of the mucosal adjuvant LTK63 and the Ag Ag85B-ESAT-6. Vaccination with LTK63/Ag85B-ESAT-6 gave a strong and sustained Th1 response mediated by IFN-gamma-secreting CD4 cells, which led to long-lasting protection against tuberculosis, equivalent to that observed with bacillus Calmette-Guérin (BCG) or Ag85B-ESAT-6 in dimethyldioctadecylammonium bromide/monophosphoryl lipid A. Because a crucial element of novel vaccine strategies is the ability to boost BCG-derived immunity, we also tested whether LTK63/Ag85B-ESAT-6 could act as a BCG booster vaccine in BCG-vaccinated mice. We found that vaccinating with LTK63/Ag85B-ESAT-6 strongly boosted prior BCG-stimulated immunity. Compared with BCG-vaccinated nonboosted mice, we observed that infection with M.tb led to a significant increase in anti-M.tb-specific CD4 T cells in the lungs of LTK63/Ag85B-ESAT-6-boosted animals. This correlated with a significant increase in the protection against M.tb in LTK63/Ag85B-ESAT-6-boosted mice, compared with BCG-vaccinated animals. Thus, LTK63/Ag85B-ESAT-6 represents an efficient preventive vaccine against tuberculosis with a strong ability to boost prior BCG immunity.
AuthorsJes Dietrich, Claire Andersen, Rino Rappuoli, T Mark Doherty, Charlotte Green Jensen, Peter Andersen
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 177 Issue 9 Pg. 6353-60 (Nov 01 2006) ISSN: 0022-1767 [Print] United States
PMID17056566 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Bacterial
  • Bacterial Proteins
  • Bacterial Toxins
  • ESAT-6 protein, Mycobacterium tuberculosis
  • Enterotoxins
  • Escherichia coli Proteins
  • Recombinant Fusion Proteins
  • Tuberculosis Vaccines
  • heat-labile enterotoxin, E coli
  • Acyltransferases
  • antigen 85B, Mycobacterium tuberculosis
Topics
  • Acyltransferases (administration & dosage, immunology)
  • Administration, Intranasal
  • Animals
  • Antigens, Bacterial (administration & dosage, immunology)
  • Bacterial Proteins (administration & dosage, immunology)
  • Bacterial Toxins (administration & dosage, immunology)
  • Enterotoxins (administration & dosage, immunology)
  • Escherichia coli Proteins (administration & dosage, immunology)
  • Immunization, Secondary
  • Mice
  • Mice, Inbred Strains
  • Mycobacterium bovis (immunology)
  • Mycobacterium tuberculosis
  • Nasal Mucosa (immunology)
  • Recombinant Fusion Proteins (administration & dosage, immunology)
  • T-Lymphocytes (immunology)
  • Tuberculosis Vaccines (administration & dosage, immunology, therapeutic use)
  • Tuberculosis, Pulmonary (prevention & control)
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: